Dr. Alfred Server was a partner in the law firm, Wilmer Cutler Pickering Hale and Dorr LLP. He joined the firm in 1993 and retired in 2012. Dr. Server focused his practice on corporate partnering in the life sciences field and was a member and former co-chair of the firm's Technology Transactions and Licensing Practice Group.
Dr. Server represented the firm's clients in some of the most significant and highly regarded strategic alliance transactions in the life sciences industry. Consistently listed as a leading life sciences transactional attorney in publications assessing legal expertise, Dr. Server was one of only two lawyers in the United States to receive the PLC Cross-border Life Sciences Handbook's highest ranking in the life sciences corporate partnering practice area from 2001 until his retirement. Companies for whom Dr. Server worked include: Millennium Pharmaceuticals; Bristol-Myers Squibb; Wyeth; Becton, Dickinson and Company; Novartis Pharmaceuticals; Incyte Corporation; TransTech Pharma; and Infinity Pharmaceuticals.
Dr. Server was also involved in the establishment of the SNP Consortium, a novel, nonprofit consortium made up of 10 of the world's leading pharmaceutical companies and a British charity. The consortium was established to identify and develop a map of genetic variation in the human genome, which has been made publicly available.
Dr. Server's recent publications include: Reach-Through Rights and the Patentability, Enforcement and Licensing of Patents on Drug Discovery Tools, Alfred C. Server, Nader Mousavi and Jane M. Love, 1 Hastings Sci. & Tech. L.J. 21 (2009); Licensee Patent Validity Challenges Following MedImmune: Implications for Patent Licensing, Alfred C. Server and Peter Singleton, 3 Hastings Sci. & Tech L.J. 243 (2011); Contract-Based Post-Sale Restrictions on Patented Products Following Quanta, Alfred C. Server and William J. Casey, 64 Hastings L.J. (in press).
Dr. Server received a JD degree from Harvard Law School. He received an AB degree, summa cum laude, from Princeton University, where he was elected to Phi Beta Kappa. His biomedical training includes an MD degree and a PhD degree (neurological sciences) from Stanford University, a medical internship at Peter Bent Brigham Hospital (a Harvard teaching hospital and predecessor of Brigham and Women's Hospital), a neurology residency at Johns Hopkins Hospital, and post-doctoral fellowships in neurovirology, genetics, and molecular biology at Johns Hopkins University, Harvard University, and the Massachusetts General Hospital. Prior to joining a law firm, Dr. Server was a founder and the research director of a biotechnology company.
Expertise: Life sciences corporate partnering; technology transactions; licensing of intellectual property; patent law; contract law
Email address: email@example.com